TFSA Investors: 2 Plunging TSX Index Stocks That Could Soar in 2020

Aphria (TSX:APHA)(NYSE:APHA) and Canada Goose Holdings (TSX:GOOS)(NYSE:GOOS) are two good stocks to buy on the dip.

| More on:
Target. Stand out from the crowd

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

While the TSX offered a very good performance in 2019 (with a year-t0-date return of about 20%), some stocks have plunged quite steeply. You may think that it’s better to avoid plunging stocks out of fear they might plunge further. While this can happen, some stocks that have fallen a lot in 2019 have good chances of soaring in 2020.

Aphria (TSX:APHA)(NYSE:APHA) and Canada Goose Holdings (TSX:GOOS)(NYSE:GOOS) are two stocks that I think are good buys on the dip, as they should deliver strong returns in 2020. 

Aphria 

Like other pot stocks this year, Aphria’s stock has plunged, falling about 10% year to date. This could be an opportunity to buy Aphria on the dip, as the stock could make huge gains in 2020. 

Aphria recently announced it has secured an $80 million credit facility for its Aphria Diamond growing facility. This credit will be made available to the Canadian cannabis firm by a major bank at a 5.5% interest rate, which is a very reasonable term. Since the announcement of this loan, Aphria’s shares have gained about 10%.

Aphria could potentially benefit from significant gains through its overseas operations while the majority of its rival companies are focused on the North American market.

Aphria won a contract in Germany that will see the pot company produce one tonne of cannabis per year, starting in the second half of 2020. Aphria estimates that German demand is already five times higher than the total production capacity attributed to Aphria and other initial German producer companies, which means that the selling price per gram could probably be higher.

Aphria is expected to boost sales by 150% to $591 million in fiscal 2020. Earnings per share should increase by 171% to $0.05 per share. Aphria is one of the few pot stocks to show profits. It has beaten analysts’ estimates by a wide margin in the last two quarters.

Canada Goose Holdings

Canada Goose is quickly becoming one of the best Canadian stocks to buy, mainly because of its prestigious brand recognition and the fact that it has turned its ridiculously expensive parkas into a must. The more expensive your product is, the stronger the brand you need to push it.

What is particularly appealing is that Canada Goose’s parkas are fast becoming a status symbol around the world, especially in China. The company recently opened stores in Boston and Tokyo, further expanding its global footprint.

Analysts expected 25% to 30% revenue growth in fiscal 2020, but Canada Goose has moderated expectations and said 20% to 25% was more feasible. Sales are expected to exceed $1 billion for fiscal 2020. The stock took a hit on the revised guidance, losing nearly 30% on a single day of trading. Year to date, the stock has plunged more than 15%. 

Canada Goose has not missed analysts’ estimates of sales and earnings in a single quarter since its IPO, and it just continues to deliver. EPS is expected to increase by 25% to $1.70 for fiscal 2020.

If the company can increase its online presence, this will have a positive effect on its sales volume and profit margins. According to Canada Goose, jackets sold online generate 2 to 4 times more operating income than the ones sold in stores.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Canada Goose Holdings.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »